Complete News, Your Way.
Published loading...Updated

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

  • A case of mpox was identified in a patient who visited Addenbrooke's Hospital emergency department on April 12, 2025, in Cambridge, UK.
  • The patient had no recent travel history or connections to other cases, leading the hospital to identify and notify a group of patients and healthcare workers as a precautionary measure.
  • Mpox, caused by a virus related to smallpox, spreads primarily through intimate, person-to-person contact and usually causes mild illness resolving within weeks without treatment.
  • A representative stated that following the visit of an individual with Mpox to their emergency unit on the evening of Saturday, 12 April, they have reached out to approximately 30 patients and 20 staff members as a safety precaution.
  • The hospital and UK Health Security Agency are monitoring the situation; the patient is isolating at home and under GP care, while the risk to the general UK population remains low.
Insights by Ground AI
Does this summary seem wrong?

29 Articles

All
Left
4
Center
6
Right
1
castanet.netcastanet.net
+7 Reposted by 7 other sources
Center

Congo faces setback in mpox response after Rwanda-backed rebels advance in the east

Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering treatment following the advance of Rwanda-backed rebels in the region.

·Kelowna, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources are Center
55% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

barlamantoday.com broke the news in on Monday, March 10, 2025.
Sources are mostly out of (0)